Kura Oncology (KURA) Return on Assets [ROA] (2011 - 2026)
Kura Oncology's Return on Assets [ROA] came in at -47.85% for Q2 2026, down 20.49 percentage points from -27.37% a year earlier and down 5.50 percentage points from the prior quarter.
Powered by 
Analysis
Kura Oncology (KURA) Return on Assets [ROA] (2011 - 2026) Analysis & Trends
For FY2025, Kura Oncology's Return on Assets [ROA] was -37.19%, down 8.41 percentage points from FY2024.
- Return on Assets [ROA] carries a three-year change of -9.76 percentage points (FY2022 to FY2025).
- Going back by year, Return on Assets [ROA] was -28.78% in FY2024 (+4.94 pp), -33.72% in FY2023 (-6.29 pp) and -27.43% in FY2022.
- The Q2 2026 figure represents the lowest quarterly Return on Assets [ROA] since Q3 2014.
- Year-over-year, Return on Assets [ROA] has declined for six consecutive quarters, with an average year-over-year change of -12.51 percentage points over the last six quarters.
- Business Quant data shows KURA's Return on Assets [ROA] at -42.36% (Q1 2026), -40.16% (Q4 2025) and -32.27% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | Kura Oncology | 947.36 Mn | 947.36 Mn | 20.63 Mn | -47.85% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -47.85% |
| Mar 31, 2026 | -42.36% |
| Dec 31, 2025 | -40.16% |
| Sep 30, 2025 | -32.27% |
| Jun 30, 2025 | -27.37% |
| Mar 31, 2025 | -23.92% |
| Dec 31, 2024 | -27.76% |
| Sep 30, 2024 | -31.15% |
| Jun 30, 2024 | -18.79% |
| Mar 31, 2024 | -9.89% |
| Dec 31, 2014 | -9.43% |
| Sep 30, 2014 | -249.24% |
| Jun 30, 2014 | -487.44% |
| Mar 31, 2014 | -358.16% |
| Dec 31, 2013 | -238.20% |
| Sep 30, 2013 | -169.48% |
| Jun 30, 2013 | -249.85% |
| Mar 31, 2013 | -452.89% |
| Dec 31, 2012 | -276.43% |
| Sep 30, 2012 | -195.18% |
API Access
Kura Oncology Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=KURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "KURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=KURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();